Insights

Strategic partnerships Recent announcements indicate collaboration with OpenLoop Health to expand access to breast cancer testing across 48 states, presenting a direct sales opportunity to digital health platforms, telehealth providers, and payer collaborations seeking enhanced screening tools.

Clinical leadership Appointment of a Medical Director with breast oncology expertise signals a focus on validated clinical integration and guideline-aligned adoption, offering entry points for hospital systems, cancer centers, and specialty clinics seeking credible biomarker-based tests.

Product expansion Breadth of proteomics based tests for early detection, including Certitude, creates cross-sell potential within oncology screening programs, primary care initiatives, and high-risk populations, especially in women’s health and breast cancer surveillance.

AI driven platform AI-enabled proteomics platform and ongoing scientific advisory board development point to opportunities with research institutions, biopharma collaborations, and diagnostic developers seeking advanced biomarker discovery and validation capabilities.

Publicity and validation Continued visibility from conferences and peer-reviewed validation of proteome-based liquid biopsy strengthens credibility with healthcare networks and payers, enabling outreach to hospital procurement, risk-based screening programs, and value-based care initiatives.

Similar companies to Astrin Biosciences

Astrin Biosciences Tech Stack

Astrin Biosciences uses 8 technology products and services including Instagram, iCIMS, Canva, and more. Explore Astrin Biosciences's tech stack below.

Media & News

Astrin Biosciences's Email Address Formats

Astrin Biosciences uses at least 2 email formats:
Astrin Biosciences Email FormatsExamplePercentage
First.Last@astrinbio.comJohn.Doe@astrinbio.com
89%
FL@astrinbio.comJD@astrinbio.com
11%

Frequently Asked Questions

What is Astrin Biosciences's official website and social media links?

Minus sign iconPlus sign icon
Astrin Biosciences's official website is astrinbio.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Astrin Biosciences generate?

Minus sign iconPlus sign icon
As of November 2026, Astrin Biosciences's annual revenue is estimated to be $1M - $10M.

What is Astrin Biosciences's NAICS code?

Minus sign iconPlus sign icon
Astrin Biosciences's NAICS code is 6215 - Medical and Diagnostic Laboratories.

How many employees does Astrin Biosciences have currently?

Minus sign iconPlus sign icon
As of November 2026, Astrin Biosciences has approximately 24 employees across 1 continents, including North America. Key team members include Chief Science Officer: J. D., Laboratory Manager: C. G. and Software Engineer: J. M. Explore Astrin Biosciences's employee directory with LeadIQ.

What industry does Astrin Biosciences belong to?

Minus sign iconPlus sign icon
Astrin Biosciences operates in the Medical and Diagnostic Laboratories industry.

What technology does Astrin Biosciences use?

Minus sign iconPlus sign icon
Astrin Biosciences's tech stack includes Instagram, iCIMS, Canva, CapCut, TikTok, Amazon Web Services, Microsoft 365 and Piwik PRO Core.

What is Astrin Biosciences's email format?

Minus sign iconPlus sign icon
Astrin Biosciences's email format typically follows the pattern of First.Last@astrinbio.com. Find more Astrin Biosciences email formats with LeadIQ.

How much funding has Astrin Biosciences raised to date?

Minus sign iconPlus sign icon
As of November 2026, Astrin Biosciences has raised $23M in funding. The last funding round occurred on Jun 11, 2024 for $23M.

When was Astrin Biosciences founded?

Minus sign iconPlus sign icon
Astrin Biosciences was founded in 2021.
Astrin Biosciences logo

Astrin Biosciences

Medical and Diagnostic LaboratoriesMinnesota, United States11-50 Employees

Astrin Biosciences is a medical and diagnostic laboratory company based in St. Paul, Minnesota. Its focus lies in cancer intelligence, aiming to speed early detection and improve cancer care. The firm develops tests that analyze early signals across more than eight thousand proteins to identify the earliest molecular changes in cancer development. The company emphasizes a patient-centric view of health decisions, highlighting the need to consider the real-life context of the person living with the condition.

In 2024, Astrin Biosciences announced a comprehensive research collaboration with Memorial Sloan Kettering Cancer Center. These activities reflect the company's positioning within the medical and diagnostic laboratory landscape as it advances cancer intelligence and early detection.

Section iconCompany Overview

NAICS Code
6215 - Medical and Diagnostic Laboratories
Founded
2021
Employees
11-50

Section iconFunding & Financials

  • $23M

    Astrin Biosciences has raised a total of $23M of funding over 1 rounds. Their latest funding round was raised on Jun 11, 2024 in the amount of $23M as a Venture Round.

  • $1M - $10M

    Astrin Biosciences's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.